348 Shares in Axon Enterprise, Inc $AXON Purchased by Alta Advisers Ltd

Alta Advisers Ltd acquired a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON) in the second quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 348 shares of the biotechnology company’s stock, valued at approximately $288,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. TCTC Holdings LLC increased its position in shares of Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after purchasing an additional 24 shares during the last quarter. Bartlett & CO. Wealth Management LLC increased its position in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after purchasing an additional 33 shares during the last quarter. Banque Transatlantique SA acquired a new stake in shares of Axon Enterprise during the 1st quarter worth about $31,000. Catalyst Capital Advisors LLC acquired a new stake in shares of Axon Enterprise during the 1st quarter worth about $32,000. Finally, Flaharty Asset Management LLC acquired a new stake in shares of Axon Enterprise during the 1st quarter worth about $33,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

Shares of AXON opened at $703.03 on Friday. The stock has a 50-day simple moving average of $755.57 and a 200-day simple moving average of $713.70. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The stock has a market capitalization of $55.19 billion, a PE ratio of 173.59, a PEG ratio of 27.30 and a beta of 1.41. Axon Enterprise, Inc has a 1 year low of $422.38 and a 1 year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. The business had revenue of $668.54 million during the quarter, compared to analysts’ expectations of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The business’s quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter last year, the business posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. On average, analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Analysts Set New Price Targets

AXON has been the subject of a number of recent analyst reports. Wolfe Research started coverage on Axon Enterprise in a research report on Monday, July 7th. They set an “outperform” rating for the company. Northland Securities set a $800.00 target price on Axon Enterprise in a research report on Tuesday, August 5th. Craig Hallum raised Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price for the company in a research report on Tuesday, August 5th. Raymond James Financial reaffirmed an “outperform” rating and issued a $855.00 target price (up from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $870.00 target price on shares of Axon Enterprise in a research report on Wednesday, September 24th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $841.64.

Insiders Place Their Bets

In other news, CFO Brittany Bagley sold 5,000 shares of Axon Enterprise stock in a transaction dated Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the completion of the transaction, the chief financial officer owned 93,592 shares in the company, valued at approximately $66,813,456.96. This trade represents a 5.07% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Hadi Partovi acquired 1,358 shares of the firm’s stock in a transaction dated Wednesday, August 13th. The stock was bought at an average price of $740.00 per share, with a total value of $1,004,920.00. Following the purchase, the director directly owned 237,938 shares in the company, valued at approximately $176,074,120. This trade represents a 0.57% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have sold 59,932 shares of company stock worth $45,115,616. Corporate insiders own 4.40% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.